Español | Portugues | English | Deutsch
SEARCH  
News
12/01/2006
Novartis is distributing the allergen vaccines of Laboratorios LETI in Germany

Laboratorios LETI and Novartis Pharma GmbH have reached an exclusive distribution agreement whereby Novartis will distribute in Germany the allergen vaccines of LETI, specifically the Depigoid and TOL-SL products. The agreement was signed by the Presid...

 
05/04/2005
Depigoid licensing approval in Germany
Laboratorios LETI S.L has obtained drug licensing approval in Germany for Depigoid vaccine for the treatment of respiratory allergy (rhinoconjunctivitis and asthma) in patients who are sensitive to mites. This licensing approval, obtained in the Paul Ehrl...